MedPath

ARJIL PHARMACEUTICALS LLC.

🇹🇼Taiwan
Ownership
-
Employees
-
Market Cap
-
Website

A Study for AR100DP1 in Mild to Moderate Atopic Dermatitis (AD)

Phase 1
Terminated
Conditions
Dermatitis, Atopic
Interventions
First Posted Date
2020-01-07
Last Posted Date
2023-12-11
Lead Sponsor
Arjil Pharmaceuticals LLC
Target Recruit Count
17
Registration Number
NCT04220411
Locations
🇨🇳

Arjil Pharmaceuticals LLC., Hsinchu, Taiwan

© Copyright 2025. All Rights Reserved by MedPath